Pay in 4 interest-free payments of $44.12 Learn more
Ships within 48 hours · Estimated delivery Sep 1 - Sep 6
If symptoms do not improve
Inhibition of this enzyme reduces intracellular cholesterol levels in hepatocytes
Before initiating Metolar 50 mg
often in conjunction with doxorubicin or cyclophosphamide
Vilitra 60mg belongs to the class of medicines called phosphodiesterase type-5 (PDE5) inhibitors
Tykerb 250 mg (Lapatinib) Quantity:90 Tablet/s If symptoms do not improveProduct Overview Tykerb 250 mg is a prescription oral medication that contains the active ingredient Lapatinib. It is manufactured by GlaxoSmithKline Pharmaceuticals Ltd and is supplied in a sealed bottle containing 30 filmcoated tablets. The product is specifically indicated for the treatment of HER2positive advanced or metastatic breast cancer, either as monotherapy or in combination with other anticancer agents such as trastuzumab. Each tablet
US$ 499.50
US$ 202.50
US$ 325.00
US$ 150.00
US$ 250.00
US$ 275.00
US$ 300.00
US$ 450.00
US$ 300.00
US$ 325.00
US$ 700.00
US$ 119.00
US$ 1894.50
US$ 164.50
